| Induction Chemo-Nivo in Unresectable Stage III NSCLC (NCT06003075) | Ralph G Zinner | 2023-12-13 |
| A Study of Acalabrutinib Plus Venetoclax and Rituximab in Participants With Treatment Naïve Mantle Cell Lymphoma (NCT05951959) | AstraZeneca | 2023-12-13 |
| Treatment of High-Risk Prostate Cancer Guided by Novel Diagnostic Radio- and Molecular Tracers (NCT06282588) | Cancer Research Antwerp | 2023-12-13 |
| A Phase I/II, Open-label Study to Investigate the Safety, Tolerability, PK, and Preliminary Efficacy of FB849 (NCT05761223) | 1ST Biotherapeutics, Inc. | 2023-12-13 |
| AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2 (NCT06219941) | AstraZeneca | 2023-12-13 |
| A Study of Efficacy, Safety, and Tolerability of KAN-101 in People With Celiac Disease (NCT06001177) | Kanyos Bio, Inc., a wholly-owned subsidiary of Anokion SA | 2023-12-13 |
| Treatment of Patients With Recurrent High-Grade Glioma With APG-157 and Bevacizumab (NCT06011109) | Aveta Biomics, Inc. | 2023-12-13 |
| Arsenic Trioxide Combined With Chemotherapy for the Treatment of p53-mutated Pediatric Cancer (NCT06088030) | Yang Li | 2023-12-13 |
| Sequential Therapy in Multiple Myeloma Guided by MRD Assessments (NCT05231629) | University of Alabama at Birmingham | 2023-12-13 |
| Safety and Efficacy of Capsule FMT in Treatment-naïve Patients With Newly Diagnosed Chronic Inflammatory Diseases (NCT04924270) | Odense University Hospital | 2023-12-13 |
| BAT1308 Combined with Platinum-Based Chemotherapy± Bevacizumab for PDL1-Positive (CPS ≥1) Cervical Cancer (NCT06123884) | Bio-Thera Solutions | 2023-12-13 |
| Study of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) for Prevention of HIV in People Who Inject Drugs (HPTN 103) (NCT06101342) | Gilead Sciences | 2023-12-13 |
| Safety and Efficacy of RRG001 Gene Therapy in Subjects With Neovascular Age-related Macular Degeneration (nAMD) (NCT06141460) | Shanghai Refreshgene Technology Co., Ltd. | 2023-12-12 |
| Clinical Study of Mitoxantrone Liposome and Azacitidine in the Treatment of R/R AITL (NCT06224842) | Huijing Wu | 2023-12-12 |
| Fecal Microbiota Transplantation for the Prevention of Acute Graft Versus Host Disease in Adults Undergoing Allogeneic Hematopoietic Cell Transplantation (NCT06026371) | Fred Hutchinson Cancer Center | 2023-12-12 |
| Detoxification of the Liver In PSC (Dolphin) (NCT05835505) | Brigham and Women's Hospital | 2023-12-12 |
| Advair HFA in Healthy and HAPE Predisposed Subjects (NCT06040268) | University of Colorado, Denver | 2023-12-12 |
| A Clinical Trial of TQ05105 Tablets Combined With TQB3617 Capsules in the Treatment of Myelofibrosis (MF) (NCT06122831) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2023-12-12 |
| A Proof of Concept and Dose-finding Study of XXB750 in Patients With Heart Failure (NCT06142383) | Novartis Pharmaceuticals | 2023-12-12 |
| PROFIL Study to Investigate the Effect of GPB on NfL Levels in Patients With Corticobasal Syndrome (CBS) (NCT05983588) | Technical University of Munich | 2023-12-12 |
| Phase II Investigation of Pembrolizumab in Combination With Bevacizumab and Oral Cyclophosphamide in Patients With High Grade Ovarian Cancer and Surgically Documented Minimal Residual Disease After Frontline Therapy (NCT06083844) | M.D. Anderson Cancer Center | 2023-12-12 |
| Administration of GV1001 for the Treatment of Progressive Supranuclear Palsy Who Completed Study GV1001-PSP-CL2-011 (NCT06235775) | GemVax & Kael | 2023-12-12 |
| A Study Evaluating Safety, Tolerability, and Clinical Activity of Forimtamig-Based Treatment Combinations in Participants With Relapsed or Refractory Multiple Myeloma (NCT06055075) | Hoffmann-La Roche | 2023-12-12 |
| Safety and Tolerability Study of GIM-122 in Subjects With Advanced Solid Malignancies (NCT06028074) | Georgiamune Inc | 2023-12-12 |
| Prevention of Paclitaxel-induced Peripheral Neuropathy in Breast Cancer Patients (NCT06135493) | Future University in Egypt | 2023-12-12 |
| Aqueous Humor Dynamics of NCX 470 Ophthalmic Solution (NCT05938699) | Nicox Ophthalmics, Inc. | 2023-12-12 |
| A Study of SI-B003 or BL-B01D1+SI-B003 in Patients With Unresectable Locally Advanced or Recurrent Metastatic HER2 Negative Breast Cancer (NCT06042894) | Sichuan Baili Pharmaceutical Co., Ltd. | 2023-12-12 |
| Safety and Efficacy of TSHA-102 in Pediatric Females With Rett Syndrome (REVEAL Pediatric Study) (NCT06152237) | Taysha Gene Therapies, Inc. | 2023-12-12 |
| ASHBY: Accelerated Super-Hypofractionated Breast Brachytherapy (NCT06185205) | Virginia Commonwealth University | 2023-12-12 |
| Donor-Derived Anti-CD33 CAR T Cell Therapy (VCAR33) in Patients With Relapsed or Refractory AML After Allogeneic Hematopoietic Cell Transplant (NCT05984199) | Vor Biopharma | 2023-12-11 |
| Pharmacological Enhancement of Glymphatic Function in Humans (NCT07432997) | Applied Cognition | 2023-12-11 |
| ONC-392 Plus Lutetium Lu 177 Vipivotide Tetraxetan in Patients With mCRPC (NCT05682443) | OncoC4, Inc. | 2023-12-11 |
| Inflammation and Depression in People With HIV (NCT05849038) | Emory University | 2023-12-11 |
| A Study of SI-B003 and BL-B01D1+SI-B003 in Patients With Locally Advanced or Metastatic Urothelial Carcinoma and Other Solid Tumors (NCT05965856) | Sichuan Baili Pharmaceutical Co., Ltd. | 2023-12-11 |
| MAXPIRe: Study to Evaluate Axatilimab in Participants With Idiopathic Pulmonary Fibrosis (IPF) (NCT06132256) | Syndax Pharmaceuticals | 2023-12-11 |
| The NODE-202 Study (Study of Etripamil Nasal Spray in Pediatric Patients) (NCT05763953) | Milestone Pharmaceuticals Inc. | 2023-12-11 |
| A First-in-human Study of PARP1 Selective Inhibitor, IMP1734, in Participants With Advanced Solid Tumors (NCT06253130) | Eikon Therapeutics | 2023-12-11 |
| A Clinical Study to Evaluate the Efficacy and Safety of REGEND001 Cell Therapy on Idiopathic Pulmonary Fibrosis (IPF) (NCT06081621) | Regend Therapeutics | 2023-12-11 |
| Epcoritamab (Epcor)-Containing Combination Salvage Therapy Followed by ASCT & Epcor Consolidation in Patients With Relapsed LBCL (NCT06287398) | Australasian Leukaemia and Lymphoma Group | 2023-12-11 |
| Frexalimab in Preservation of Endogenous Insulin Secretion Compared to Placebo in Adults, Adolescents and Children on Top of Insulin Therapy (FABULINUS) (NCT06111586) | Sanofi | 2023-12-11 |
| Compare the Perioperative Analgesic Effect of Ultrasound Guided Thoracic Paravertebral Block and Ultrasound Guided Serratus Anterior Block in Patients Undergoing Thoracotomy (NCT06831578) | Menoufia University | 2023-12-10 |
| Fluzoparib With or Without Apatinib in Platinum-sensitive Relapsed Ovarian Cancer Previously Treated With PARPi (NCT06161272) | Guangxi Medical University | 2023-12-10 |
| Mesenchymal Stem Cells Treatment for AIDS Patients at Late Stage (NCT05939167) | Cell Energy Life Sciences Group Co. LTD | 2023-12-10 |
| A Phase Ⅱ Clinical Study of Adebrelimab Combined With Chemotherapy and Concurrent Radiotherapy for Extensive-Stage Oligometastatic SCLC (NCT06177925) | Nanfang Hospital, Southern Medical University | 2023-12-10 |
| Phase 2 Study of HEC88473 Injection in Subjects With Type 2 Diabetes Mellitus (NCT06148649) | Dongguan HEC Biopharmaceutical R&D Co., Ltd. | 2023-12-10 |
| Validity of Ozonated Olive Oil Gel Versus Injectable Bone Graft (NCT07368114) | Suez Canal University | 2023-12-10 |
| Benefits of Trimetazidine in MASLD Patients (NCT06140953) | October 6 University | 2023-12-10 |
| Phase II Study of Ovulation in Obese Women (NCT06306131) | InnovaGyn, Inc. | 2023-12-10 |
| A Phase 2a Study of HT-6184 in Subjects With IPSS-R Very Low, Low or Intermediate Risk MDS and Anemia (NCT07052006) | Halia Therapeutics, Inc. | 2023-12-09 |
| To Evaluate The Safety and Initial Efficacy of STSA-1002 Injection in Patients With Acute Respiratory Distress Syndrome (NCT06038916) | Staidson (Beijing) Biopharmaceuticals Co., Ltd | 2023-12-09 |
| Single and Multiple Ascending Oral Doses of Avenanthramide (NCT06101784) | Montreal Heart Institute | 2023-12-09 |
| Upper Limb Somatosensory Discrimination Therapy and Dose-matched Motor Therapy in Children and Adolescents With Unilateral Cerebral Palsy (NCT06006065) | Hilde Feys | 2023-12-09 |
| Combined DEB-TACE, Lenvatinib and Pucotenlimab as Conversion Therapy for Unresectable Intrahepatic Cholangiocarcinoma (NCT06192784) | Tongji Hospital | 2023-12-09 |
| Evaluation of 611 in Chinese Adults With Moderate to Severe Chronic Obstructive Pulmonary Disease (NCT06099652) | Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | 2023-12-08 |
| A Study to Learn About the Study Medicine Sisunatovir in Adults With Respiratory Syncytial Virus (RSV) Infection (NCT06079320) | Pfizer | 2023-12-08 |
| A Clinical Trial of LBL-024 Combined With Etoposide and Platinum in Patients With Advanced Neuroendocrine Carcinoma (NCT06157827) | Nanjing Leads Biolabs Co.,Ltd | 2023-12-08 |
| Study to Evaluate TNG348 Alone and With a PARP Inhibitor in Patients With BRCA 1/2 Mutant or HRD+ Solid Tumors (NCT06065059) | Tango Therapeutics, Inc. | 2023-12-08 |
| A Clinical Study of TQC2731 Injection in the Treatment of Chronic Rhinosinusitis With Nasal Polyps (NCT06036927) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2023-12-08 |
| HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD Prophylaxis (NCT06001385) | Center for International Blood and Marrow Transplant Research | 2023-12-08 |
| SBRT Followed by Neoadjuvant Chemoimmunotherapy of Sindilizumab Plus Docetaxel and Cisplatin for Locoregionally Advanced Squamous Carcinoma of Oral Cavity and Oropharynx (NCT06219980) | Sun Yat-sen University | 2023-12-07 |
| The Role of Anifrolumab in Improving Markers of Vascular Risk in Patients With Systemic Lupus Erythematosus (SLE) - IFN-CVD (NCT05440422) | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 2023-12-07 |
| Study of DNL126 in Pediatric Participants With Mucopolysaccharidosis Type IIIA (Sanfilippo Syndrome Type A) (NCT06181136) | Denali Therapeutics Inc. | 2023-12-07 |
| Phase 2 Study of the RSV/Flu-01E Vaccine Against Respiratory Syncytial Virus Infection in Older Adults (NCT06890429) | Research Institute of Influenza, Russia | 2023-12-07 |
| Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States (NCT05832229) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2023-12-07 |
| Amantadine Therapy for Cognitive Impairment in Long COVID (NCT06055244) | Ohio State University | 2023-12-07 |
| A Study of AMDX-2011P in Participants With Primary Open Angle Glaucoma (NCT06223048) | Amydis Inc. | 2023-12-07 |
| Assessment of Biomarker-Guided CNI Substitution In Kidney Transplantation (NCT05917522) | National Institute of Allergy and Infectious Diseases (NIAID) | 2023-12-07 |
| A Dose-response Study of Tranexamic Acid in Total Hip Arthroplasty (NCT03822793) | Centre Hospitalier Universitaire de Saint Etienne | 2023-12-07 |
| Randomized Study of Carbon Ion Boost in Hypoxic Lesions for Locally Advanced Non-small Cell Lung Cancer (NCT06205927) | Jian Chen | 2023-12-07 |
| A Clinical Study of TQA3605 Tablets Monotherapy or in Combination With Nucleoside (Acid) Analogues in Treatment Naive and Treated Patients With Chronic Hepatitis B (NCT06150014) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2023-12-07 |
| Trial of a Six-Month Regimen of High-Dose Rifampicin, High-Dose Isoniazid, Linezolid, and Pyrazinamide Versus a Standard Nine-Month Regimen for the Treatment of Adults and Adolescents With Tuberculous Meningitis (NCT05383742) | National Institute of Allergy and Infectious Diseases (NIAID) | 2023-12-07 |
| Atezolizumab Immunotherapy With or Without Tiragolumab for Patients With Unresectable Stage III NSCLC (NCT05798663) | Alliance Foundation Trials, LLC. | 2023-12-07 |
| A Study of LY3972406 in Adult Participants With Moderate-to-Severe Plaque Psoriasis (NCT06176768) | Eli Lilly and Company | 2023-12-06 |
| Pembrolizumab and Mogamulizumab in Advanced-stage, Relapsed/Refractory Cutaneous T-cell Lymphomas (NCT05956041) | University of Michigan Rogel Cancer Center | 2023-12-06 |
| Testing Immunotherapy (Atezolizumab) With or Without Chemotherapy in Locoregional MSI-H/dMMR Gastric and Gastroesophageal Junction (GEJ) Cancer (NCT05836584) | National Cancer Institute (NCI) | 2023-12-06 |
| First-in-human Interleukin-15-transpresenting Wilms' Tumor Protein 1-targeting Autologous Dendritic Cell Vaccination in Cancer Patients (NCT05964361) | University Hospital, Antwerp | 2023-12-06 |
| Oral Azacitidine Combined With Venetoclax in Previously Untreated Higher-risk Myelodysplastic Syndromes (NCT05782127) | Groupe Francophone des Myelodysplasies | 2023-12-06 |
| A Phase Ib/II Study Of JS015 Combination Therapy in Advanced Solid Tumors (NCT06139211) | Shanghai Junshi Bioscience Co., Ltd. | 2023-12-06 |
| Adaptive Trial Scheduling in Naming Treatment for Aphasia (NCT05653466) | University of Pittsburgh | 2023-12-06 |
| Phase II Study of Artesunate Ointment for the Treatment of Vulvar High Grade Squamous Intraepithelial Lesions (Vulvar HSIL, VIN2/3) (NCT06075264) | Frantz Viral Therapeutics, LLC | 2023-12-06 |
| Belumosudil for the Pre-emptive Treatment of Patients With Chronic Graft Versus Host Disease (NCT05996627) | Fred Hutchinson Cancer Center | 2023-12-06 |
| Study of AR-14034 in Participants With Neovascular Age-Related Macular Degeneration (nAMD) (NCT05769153) | Alcon Research | 2023-12-06 |
| Assessing the Safety, Immune Response, and Early Efficacy of a Candida Vaccine in Women With Recurrent Vulvovaginal Candidiasis: A Randomized Controlled Study (NCT06190509) | LimmaTech Biologics AG | 2023-12-06 |
| A Dose Escalation and Expansion Study of [177Lu]Lu-SN201 in Participants With Advanced Cancer (NCT06184035) | Spago Nanomedical AB | 2023-12-06 |
| Teriflunomide for Steroid-resistant/Relapse Immune Thrombocytopenia (NCT06190145) | Peking University People's Hospital | 2023-12-05 |
| Study of a Novel Type 3 Oral Poliomyelitis Vaccine in Panama (NCT05654467) | PATH | 2023-12-05 |
| HyBryte (Synthetic Hypericin) Versus Valchlor (Mechlorethamine) in the Treatment of CTCL (NCT06149247) | Soligenix | 2023-12-05 |
| Anthrax AV7909 Boost Evaluation Study (NCT05997264) | Biomedical Advanced Research and Development Authority | 2023-12-05 |
| IRI-EXPLORE: A Study to Test Whether BI 765845 Helps People Who Have Had a Heart Attack (NCT06139328) | Boehringer Ingelheim | 2023-12-05 |
| Neurotization of the Nipple Areolar Complex to Restore Sensation for Patients With Breast Cancer Undergoing Nipple Sparing Mastectomy and Reconstruction (NCT06153836) | Mayo Clinic | 2023-12-05 |
| A Study Evaluating The Efficacy and Safety of Neoadjuvant Immunotherapy Combinations in Patients With Surgically Resectable Hepatocellular Carcinoma (NCT05908786) | Hoffmann-La Roche | 2023-12-05 |
| The Combination of Teriflunomide and Danazol for Steroid-resistant/Relapse Immune Thrombocytopenia (NCT06176911) | Peking University People's Hospital | 2023-12-05 |
| A Single-center, Prospective, Two Cohort Study of Surufatinib Combined With AG or AG in the First-line Treatment of Locally Advanced or Metastatic Pancreatic Cancer (NCT05969171) | Fudan University | 2023-12-05 |
| A Study of Glipizide to Treat High Blood Sugar in People With Pancreatic Cancer (NCT06168812) | Memorial Sloan Kettering Cancer Center | 2023-12-05 |
| Clinical Trial of High Dose Lisdexamfetamine and Contingency Management in MA Users (NCT05854667) | Centre hospitalier de l'Université de Montréal (CHUM) | 2023-12-05 |
| A First-in-human Dose Escalation and Expansion Study to Evaluate the Safety, and Tolerability of AZD8421 Alone or in Combination in Participants With Selected Advanced or Metastatic Solid Tumors (NCT06188520) | AstraZeneca | 2023-12-05 |
| AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Multiple Myeloma (NCT06106945) | AstraZeneca | 2023-12-05 |
| CAN-DOSE Study: Cessation With Augmented Nicotine for Dual Use Of Smoking and E-cigarettes (NCT06087328) | Medical University of South Carolina | 2023-12-05 |
| Study of Tilpisertib Fosmecarbil in Participants With Moderately to Severely Active Ulcerative Colitis (NCT06029972) | Gilead Sciences | 2023-12-05 |
| A Randomised, Controlled Trial of a Low-energy Diet for Improving Functional Status in Heart Failure With PRESERVED Ejection Fraction Preserved Ejection Fraction (NCT05887271) | University of Leicester | 2023-12-05 |